As of January 2025 Basilea Pharmaceutica has a market cap of S$0.77 Billion. This makes Basilea Pharmaceutica the world's 6596th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | S$0.77 B | 1.45% |
2024 | S$0.76 B | 15.6% |
2023 | S$0.66 B | -16.14% |
2022 | S$0.79 B | 10.48% |
2021 | S$0.71 B | -17.28% |
2020 | S$0.86 B | 23.35% |
2019 | S$0.70 B | 17.83% |
2018 | S$0.59 B | -47.28% |
2017 | S$1.13 B | 0.76% |
2016 | S$1.12 B | -24.6% |
2015 | S$1.48 B | 14.32% |
2014 | S$1.30 B | -15.16% |
2013 | S$1.53 B | 167.94% |
2012 | S$0.57 B | 21.27% |
2011 | S$0.47 B | -44.99% |
2010 | S$0.85 B | 2.43% |
2009 | S$0.83 B | -57.09% |
2008 | S$1.95 B | -26.94% |
2007 | S$2.67 B | 28.87% |
2006 | S$2.07 B | 59.8% |
2005 | S$1.29 B | 35.95% |
2004 | S$0.95 B |